C. Hiesse

发表

Sirolimus May Reduce Fertility in Male Renal Transplant Recipients

C. Elie, E. Thervet, F. Martinez, 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

High pulse pressure associated with cardiovascular events in patients with type 2 diabetes undergoing hemodialysis.

C. Hiesse, K. Hue, J. Deloumeaux, 2005, American journal of hypertension.

Confirmation of the interaction between cyclosporine and the calcium channel blocker nicardipine in renal transplant patients.

B. Charpentier, C. Hiesse, M. Cantarovich, 1987, Clinical nephrology.

Analysis of skin cancer risk factors in immunosuppressed renal transplant patients shows high levels of UV-specific tandem CC to TT mutations of the p53 gene.

J. Armand, Lionel Luron, S. Queillé, 2006, Carcinogenesis.

Posttransplant Major Histocompatibility Complex Class I Chain-Related Gene A Antibodies and Long-Term Graft Outcomes in a Multicenter Cohort of 779 Kidney Transplant Recipients

D. Abramowicz, M. Andrien, M. Toungouz, 2012, Transplantation.

Malignancy after renal transplantation: analysis of incidence and risk factors in 1700 patients followed during a 25-year period.

P. Rieu, B. Charpentier, C. Hiesse, 1997, Transplantation proceedings.

Recurrence of immunoglobulin A nephropathy after renal transplantation in the cyclosporine era.

M. Kessler, B. Charpentier, C. Hiesse, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Long-term outcome of kidney transplantation in patients with systemic lupus erythematosus: a multicenter study. Groupe Cooperatif de Transplantation d'île de France.

P. Grimbert, P. Lang, C. Antoine, 1998, Transplantation.

Long-term outcome of kidney transplantation in patients with systemic lupus erythematosus: a multicenter study. Groupe Cooperatif de Transplantation d'île de France.

P. Grimbert, P. Lang, C. Antoine, 1998, Transplantation.

Renal transplantation in patients with systemic lupus erythematosus: a multicenter study.

P. Grimbert, P. Lang, C. Antoine, 1997, Transplantation proceedings.

LONG-TERM OUTCOME OF KIDNEY TRANSPLANTATION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

P. Grimbert, P. Lang, C. Antoine, 1998 .

EVIDENCE THAT ANTIHUMAN TUMOR NECROSIS FACTOR MONOCLONAL ANTIBODY PREVENTS OKT3‐INDUCED ACUTE SYNDROME

C. Ferran, L. Chatenoud, O. Lantz, 1992, Transplantation.

INDUCTION VERSUS NONINDUCTION IN RENAL TRANSPLANT RECIPIENTS WITH TACROLIMUS-BASED IMMUNOSUPPRESSION1

J. Squifflet, F. Berthoux, L. Rostaing, 2001, Transplantation.

Multivariate analysis of donor risk factors for graft survival in kidney transplantation

C. Pouteil‐Noble, M. Kessler, P. Tuppin, 2003, Transplantation.

Donor‐Estimated GFR as an Appropriate Criterion for Allocation of ECD Kidneys into Single or Dual Kidney Transplantation

E. Thervet, F. Martinez, C. Legendre, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Retrospective follow-up of transplantation of kidneys from 'marginal' donors.

P. Grimbert, P. Lang, E. Rondeau, 2006, Kidney international.

In situ expression of cell growth factors in human renal chronic graft rejection.

C. Legendre, B. Charpentier, C. Hiesse, 1997, Transplantation proceedings.

Spondylodiskitis due to Candida albicans: report of two patients who were successfully treated with fluconazole and review of the literature.

C. Hennequin, B. Charpentier, C. Hiesse, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Development of renal dysfunction and renal histological lesions in two patients treated with FK 506 for acute rejection following liver transplantation.

D. Samuel, H. Bismuth, P. Callard, 1991, Transplantation proceedings.

Peripheral T Cell Tolerance

O. Lantz, B. Charpentier, C. Hiesse, 1994 .

The case to abandon human leukocyte antigen matching for kidney allocation: would it be wise to throw out the baby with the bathwater?

D. Houssin, C. Hiesse, F. Pessione, 2004, Transplantation.

Hemolytic Uremic Syndrome: Recurrence after Renal Transplantation

P. Lang, D. Glotz, C. Baron, 2000 .

Transplant renal artery stenosis: experience and comparative results between surgery and angioplasty

B. Charpentier, C. Hiesse, G. Benôit, 1990, Transplant international : official journal of the European Society for Organ Transplantation.

Gastrointestinal complications in renal transplantation

H. Bensadoun, B. Charpentier, C. Hiesse, 1993, Transplant international : official journal of the European Society for Organ Transplantation.

Gastrointestinal complications in renal transplantation

H. Bensadoun, B. Charpentier, C. Hiesse, 1991, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Analysis of incidence and pattern of acute rejection episodes after simultaneous pancreas and kidney transplantation.

V. Paradis, B. Charpentier, C. Hiesse, 1997, Transplantation proceedings.

Single-center experience with cyclosporine therapy for kidney transplantation: analysis of a twenty-year period in 1200 patients.

R. Snanoudj, S. Beaudreuil, B. Charpentier, 2004, Transplantation proceedings.

Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Groupe Cooperatif de Transplantation d' Ile de France (GCIF).

C. Pellet, J. Golmard, T. Schulz, 1999, Transplantation.

Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Groupe Cooperatif de Transplantation d' Ile de France (GCIF).

C. Pellet, J. Golmard, T. Schulz, 1999, Transplantation.

Diagnosis and management of asymptomatic bacteriuria in kidney transplant recipients: a survey of current practice in Europe

E. Frangou, P. Kes, K. Lopau, 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Incidence of transport medium contamination in cadaver kidney procurement.

H. Bensadoun, R. Tiguert, C. Hiesse, 1988, Transplantation Proceedings.

Impact of targeted hypothermia in expanded-criteria organ donors on recipient kidney-graft function: study protocol for a multicentre randomised controlled trial (HYPOREME)

K. Asehnoune, L. Rostaing, A. Heng, 2022, BMJ Open.

[Inequalities to the access of renal transplantation for French patients living in the overseas French territories].

P. Tuppin, C. Hiesse, Y. Chalem, 2004, Nephrologie.

Long-term results and risk factors of quadruple immunosuppression in renal transplantation.

B. Charpentier, C. Hiesse, G. Benôit, 1999, Transplantation proceedings.

Multicenter trial of one HLA-DR-matched or mismatched blood transfusion prior to cadaveric renal transplantation.

P. Bierling, P. Lang, D. Glotz, 2001, Kidney international.

EULID project: European living donation and public health.

C. Ballesté, M. Manyalich, A. Nanni Costa, 2009, Transplantation proceedings.

[Encrusted pyelo-ureteritis and cystitis by Corynebacterium D2 in a renal transplant].

V. Meignin, J. Quillard, A. Vieillefond, 1996, Annales de pathologie.

Imaging analysis of encrusted cystitis and pyelitis in renal transplantation.

B. Charpentier, A. Vieillefond, C. Hiesse, 1995, Transplantation proceedings.

[Disseminated cutaneous leishmaniasis in a case of an immunodepressed woman].

O. Lantz, J. Rioux, A. Vieillefond, 1993, Annales de dermatologie et de venereologie.

Nonrandomized comparative study between University of Wisconsin cold storage and Euro-Collins solution in kidney transplantation.

H. Bensadoun, H. Bittard, B. Charpentier, 1990, Transplantation proceedings.

[Comparative study of the University of Wisconsin solution versus Eurocollins in kidney transplant].

H. Bensadoun, B. Charpentier, C. Hiesse, 1989, Annales d'urologie.

Incidence and type of malignancies occurring after renal transplantation in conventionally and in cyclosporine-treated recipients: single-center analysis of a 20-year period in 1600 patients.

B. Charpentier, C. Hiesse, G. Benôit, 1995, Transplantation proceedings.

Organ procurement by a transplant team outside of its original center: results of renal transplantation.

B. Charpentier, A. Decaux, C. Hiesse, 1998, Transplantation proceedings.

Interaction between theophylline and tacrolimus in a renal transplant patient.

O. Lambotte, B. Charpentier, C. Hiesse, 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Post-transplantation polyomavirus infections.

B. Charpentier, C. Hiesse, F. Kriaa, 1999, Journal of nephrology.

Human parvovirus B19 infection in organ transplant recipients

B. Charpentier, C. Hiesse, J. Cartron, 1999, Clinical transplantation.

Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score.

R. Porcher, A. Heng, O. Toupance, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Urinary complications after kidney transplantation can be reduced.

H. Bensadoun, B. Charpentier, C. Hiesse, 2000, Transplantation proceedings.

Surgical complications in kidney transplantation.

H. Bensadoun, B. Charpentier, C. Hiesse, 1994, Transplantation proceedings.

Attempt at depletion of anti-HLA antibodies in sensitized patients awaiting transplantation using extracorporeal immunoadsorption, polyclonal IgG, and immunosuppressive drugs.

O. Lantz, C. Hiesse, J. Brocard, 1989, Transplantation proceedings.

Prognostic value of quantitative Kaposi sarcoma--associated herpesvirus load in posttransplantation Kaposi sarcoma.

S. Chevret, C. Pellet, D. Samuel, 2002, The Journal of infectious diseases.

High rate of success in kidney cadaveric retransplantation with optimal matching and potent immunosuppression.

H. Bensadoun, O. Lantz, B. Charpentier, 1990, Transplantation proceedings.

Cytotoxic T lymphocyte changes after HLA-DR match and HLA-DR mismatch blood transfusions.

V. Baudouin, C. Hiesse, S. Legouvello, 1997, Transplantation.

Cytokine mRNA and protein expression in a mixed leukocyte reaction before and after allogeneic transfusions. Groupe Coopératif de Transplantation d'Ile de France.

H. Ansart‐Pirenne, V. Baudouin, C. Hiesse, 1998, Transplantation.

Incidence and consequences of post-transplantation lymphoproliferative disorders.

B. Charpentier, C. Hiesse, F. Kriaa, 1997, Journal of nephrology.

Membranous nephropathy in a bone marrow transplant recipient.

B. Charpentier, D. Machover, E. Goldschmidt, 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Treatment of renal artery stenosis after renal transplantation.

H. Bensadoun, B. Charpentier, C. Hiesse, 1987, Transplantation proceedings.

Thirty-three pregnancies in a population of 1725 renal transplant patients.

P. Rieu, B. Charpentier, C. Hiesse, 1997, Transplantation proceedings.

Posttransplant diabetes mellitus in kidney transplant recipients under tacrolimus immunosuppression.

B. Charpentier, C. Hiesse, G. Benôit, 2000, Transplantation proceedings.

[Treatment of mycotic aneurysms after renal transplantation].

H. Bensadoun, B. Charpentier, C. Hiesse, 1988, Annales d'Urologie.

Benefits of vena cava removal with the renal vein in cadaver kidney procurement: incidence of arterial complications.

H. Bensadoun, B. Charpentier, C. Hiesse, 1988, Transplantation Proceedings.

[Arterial stenosis in the renal graft. Spontaneous evolution in 40 cases].

H. Bensadoun, O. Lantz, B. Charpentier, 1991, Presse medicale.

[Arterial stenosis in the renal graft. Indication for endoluminal dilatation].

H. Bensadoun, B. Charpentier, C. Hiesse, 1991, Presse medicale.

De novo and recurrent diseases: recurrent glomerulopathies.

B. Charpentier, A. Durrbach, C. Hiesse, 1999, Transplantation proceedings.

Five years' experience at one centre with protein A immunoadsorption in patients with deleterious allo/autoantibodies (anti-HLA antibodies, autoimmune bleeding disorders) and post-transplant patients relapsing with focal glomerular sclerosis.

B. Charpentier, C. Hiesse, G. Tchernia, 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Recurrent essential mixed cryoglobulinemia in renal allografts. Report of two cases and review of the literature.

O. Lantz, B. Charpentier, B. Moulin, 1989, American journal of nephrology.

Hemolytic uremic syndrome. Recurrence after renal transplantation. Groupe Coopératif de l'Ile-de-France (GCIF).

C. Legendre, P. Lang, D. Glotz, 2000, Medicine.

20-Year Follow-Up Results of a Randomized Controlled Trial Comparing Antilymphocyte Globulin Induction to No Induction in Renal Transplant Patients

M. Ladouceur, B. Charpentier, A. Durrbach, 2008, Transplantation.

[Value of procuring the right kidney with the infrarenal inferior vena cava for transplantation].

B. Charpentier, C. Hiesse, G. Benôit, 1988, Presse medicale.

[Autosomal dominant polycystic kidney in adults and transplantation].

H. Bensadoun, C. Hiesse, G. Benôit, 1990, Annales d'urologie.

Late graft failure and death in renal transplant recipients: analysis in a single-center population of 1500 patients.

P. Rieu, B. Charpentier, C. Hiesse, 1997, Transplantation proceedings.

[Results of the treatment of renal artery stenosis in transplanted kidneys].

H. Bensadoun, B. Charpentier, C. Hiesse, 1987, Annales d'urologie.

[Urologic complications in kidney transplantations. Indication for endo-urologic techniques].

H. Bensadoun, O. Lantz, C. Hiesse, 1991, Presse medicale.

[Urological complications in renal transplantation].

H. Bensadoun, O. Lantz, B. Charpentier, 1991, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Quality of life in adult survivors beyond 10 years after liver, kidney, and heart transplantation

Didier Samuel, Christian Hiesse, D. Samuel, 2003, Transplantation.

Lymphocytotoxic antibody responses to one prospective HLA-DR typed blood transfusion in naive patients awaiting renal transplantation. The Groupe Coopératif de Transplantation de l'Ile de France.

P. Bierling, M. Busson, C. Hiesse, 1997, Transplantation proceedings.

Transfusion protocols prior to renal transplantation: questionnaire on current attitudes at French centers. Société Française Tranplantation.

C. Hiesse, P. Lang, 1995, Transplantation proceedings.

Systemic and kidney toxicity of intraocular administration of vascular endothelial growth factor inhibitors.

M. Delahousse, J. Duong van Huyen, V. Frémeaux-Bacchi, 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

From combined heart–kidney to kidney transplantation program: what nephrologists should know about dilated cardiomyopathy

C. Hiesse, C. Ridel, M. Touzot, 2021, Transplant international : official journal of the European Society for Organ Transplantation.

Renal transplantation and active lupus erythematosus.

O. Lantz, B. Charpentier, C. Hiesse, 1988, Annals of Internal Medicine.

Triple combination of low-dose cyclosporine, azathioprine, and steroids in first cadaver donor renal allografts.

P. Rieu, B. Charpentier, C. Hiesse, 1987, Transplantation proceedings.

Multiple drug combinations with “low-dose” cyclosporin for renal transplantation

O. Lantz, B. Charpentier, M. Busson, 1988, Transplant international : official journal of the European Society for Organ Transplantation.

Multiple drug combinations with “low‐dose” cyclosporin for renal transplantation: Multivariate analysis of risk factors determining short‐term graft survival within one renal transplant center

O. Lantz, B. Charpentier, M. Busson, 1988 .

Diabetes mellitus after renal transplantation: characteristics, outcome, and risk factors.

P. Lang, M. Busson, C. Hiesse, 1996, Transplantation.

European Living Donation and Public Health (EULID Project)

Alessandro Nanni Costa, C. Ballesté, M. Manyalich, 2010 .

Psychosocial risk factors for impaired health-related quality of life in living kidney donors: results from the ELIPSY prospective study

C. Papachristou, C. Ballesté, M. Manyalich, 2020, Scientific Reports.

GANCICLOVIR FOR CYTOMEGALOVIRUS INFECTION IN RENAL TRANSPLANT RECIPIENTS

Y. Pirson, M. Reynaert, P. Gianello, 1989, The Lancet.

Long-term results of combined kidney and liver transplantation at one center.

D. Samuel, H. Bismuth, B. Charpentier, 1997, Transplantation proceedings.

Combined liver and kidney transplantation in patients with chronic nephritis associated with end-stage liver disease.

D. Samuel, H. Bensadoun, H. Bismuth, 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Treatment of cytomegalovirus infections in renal transplant recipients with 9-(1,3-dihydroxy-2-propoxymethyl) guanine.

O. Lantz, B. Charpentier, C. Hiesse, 1988, Transplantation.

Functional results in kidneys procured from pediatric cadavers.

B. Charpentier, C. Hiesse, G. Benôit, 2000, Transplantation Proceedings.

[Acute clinical syndrome associated with OKT3 administration. Prevention by single injection of an anti-human TNF monoclonal antibody].

C. Ferran, L. Chatenoud, O. Lantz, 1991, Presse medicale.

Therapeutic intervention on preformed anti-HLA antibodies

B. Charpentier, C. Hiesse, G. Benôit, 1997 .

Living donor psychosocial assesment/follow-up practices in the partners' countries of the ELIPSY project.

C. Papachristou, C. Ballesté, M. Manyalich, 2012, Transplantation proceedings.

Immunoadsorption of anti-HLA antibodies for highly sensitized patients awaiting renal transplantation.

B. Charpentier, C. Hiesse, P. Rousseau, 1992, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Organ donors > or = 60 years: harvesting disparities in French regional areas.

E. Diène, P. Tuppin, C. Hiesse, 2002, Transplantation proceedings.

Living with a functioning kidney transplant at 74 yr or older: a national epidemiological study

C. Jacquelinet, B. Giraudeau, H. Nivet, 2004, Clinical transplantation.

SAFETY OF TRIPLE IMMUNOSUPPRESSIVE TREATMENT (CYCLOSPORIN, AZATHIOPRINE AND PREDNISOLONE)

B. Charpentier, C. Hiesse, D. Fries, 1985, The Lancet.

Prophylactic use of the anti-IL-2 receptor monoclonal antibody LO-Tact-1 in cadaveric renal transplantation: results of a randomized study.

O. Lantz, H. Bazin, B. Charpentier, 1993, Transplantation proceedings.

Prophylactic use of the IL‐2 receptor‐specific monoclonal antibody LO‐Tact‐1 with cyclosporin A and steroids in renal transplantation

H. Bensadoun, O. Lantz, H. Bazin, 1992 .

Overview of clinical trials with new agents.

B. Charpentier, A. Durrbach, C. Hiesse, 2001, Transplantation Proceedings.